Showing results (431-440 of 606) with videos related to

Sort By:
Pageof 61
The American Journal of Cardiology|April 13, 2015
Prognostic value of serial B-type natriuretic peptide measurement in transcatheter aortic valve replacement (from the PARTNER Trial)Brian P O'Neill, Mayra Guerrero, Vinod H Thourani, et al.
The Annals of Thoracic Surgery|August 24, 2014
Aortic and mitral valve replacement versus transcatheter aortic valve replacement in propensity-matched patientsFenton H McCarthy, Nimesh D Desai, Howard C Herrmann, et al.
The New England Journal of Medicine|April 5, 2019
Procedural Volume and Outcomes for Transcatheter Aortic-Valve ReplacementSreekanth Vemulapalli, John D Carroll, Michael J Mack, et al.
Circulation. Genomic and Precision Medicine|January 14, 2020
Prospective CYP2C19 Genotyping to Guide Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Pragmatic Randomized Clinical TrialSony Tuteja, Henry Glick, William Matthai, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 17, 2009
Effect of percutaneous mitral repair with the MitraClip device on mitral valve area and gradientHoward C Herrmann, Saibal Kar, Robert Siegel, et al.
The Annals of Thoracic Surgery|March 6, 2018
Association of Tricuspid Regurgitation With Transcatheter Aortic Valve Replacement Outcomes: A Report From The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy RegistryFenton H McCarthy, Sreekanth Vemulapalli, Zhuokai Li, et al.
Circulation|September 3, 2017
Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Insights from the National Cardiovascular Data Registry Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy RegistryMatthew C Hyman, Sreekanth Vemulapalli, Wilson Y Szeto, et al.
Lancet (London, England)|September 21, 2002
Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up studyDavid J Moliterno, Steven J Yakubov, Peter M DiBattiste, et al.
Circulation|May 22, 2002
Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET TrialGregg W Stone, David J Moliterno, Michel Bertrand, et al.
Circulation. Cardiovascular Interventions|September 5, 2020
Association Between 90-Minute Door-to-Balloon Time, Selective Exclusion of Myocardial Infarction Cases, and Access Site Choice: Insights From the Cardiac Care Outcomes Assessment Program (COAP) in Washington StateAshwin S Nathan, Swathi Raman, Nancy Yang, et al.
Pageof 61